Atlas Trials

Irinotecan Liposome Combined with S-1 in PD-1/L1 Inhibitor Refractory Recurrent or Metastatic NPC

Clinical trial NCT06657690 · RECRUITING

Trial details

NCT number
NCT06657690
Sponsor
Sun Yat-sen University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Recurrent or Metastatic Nasopharyngeal Carcinoma
Start date
2024-11-01
Primary completion
2026-10-31
Enrollment
56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.